Sanuwave Health, Inc. announced record Q4 2025 revenues of $13.4 million (up 29.7% YoY) and full year 2025 revenues of $44.1 million (up 35.0% YoY), with Q4 GAAP operating income of $2.0 million and full year net income of $11.8 million. The company issued Q1 2026 revenue guidance of $9.6-10.3 million and full year 2026 guidance of $51.0-55.0 million.
Key takeaways
Q4 2025 revenue $13.4 million, up 29.7% from $10.3 million in Q4 2024
Full year 2025 revenue $44.1 million, up 35.0% from $32.6 million in 2024
Q4 2025 gross margin 74.7% vs 77.9% in Q4 2024; full year 77.1% vs 75.2%
Q4 2025 GAAP operating income $2.0 million; full year $4.9 million
Q4 2025 net income $7.7 million; full year $11.8 million
Q1 2026 revenue guidance $9.6-10.3 million (3-10% growth); FY2026 $51.0-55.0 million (16-25% growth)